Cerus (CERS) vs Shoulder Innovations (SI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cerus (CERS) has outperformed Shoulder Innovations (SI) over the past year, gaining 43.1% versus a gain of 42.8%. Cerus is the larger company by market cap ($459.5 million vs $372.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | SI |
|---|---|---|
| Share price | $2.28 | $17.89 |
| Market cap | $459.48M | $372.45M |
| 1-day change | -0.44% | -4.38% |
| YTD return | +11.17% | +30.84% |
| 1-year return | +43.13% | +42.82% |
| 5-year return | -62.58% | — |
| P/E ratio (TTM) | — | 22.09 |
| EPS (TTM) | $-0.03 | $0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $24.60 |
| 52-week low | $1.38 | $10.92 |
| Distance from 52-week high | -34.29% | -27.26% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +125.00% | +46.73% |
| Average volume | 2.13M | 116.50K |
| Shares outstanding | 201.52M | 20.82M |
| Employees | 261 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Health Care · Medical/Dental Instruments · 261 employees
CERS vs SI FAQ
Which is bigger, Cerus or Shoulder Innovations?
Cerus (CERS) is larger, with a market capitalization of $459.48M compared with $372.45M for Shoulder Innovations (SI).
Which stock has performed better over the past year, CERS or SI?
CERS returned +43.13% over the past 12 months, compared with +42.82% for SI (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and Shoulder Innovations in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.